Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid and Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT04820894
What this trial is testing

Perception of Cure Among Patients With Metastatic Cancer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid Neoplasm
City of Hope Medical Center
Early research (Phase 1)Ended earlyNCT06870487
What this trial is testing

Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

Who this might be right for
Peripheral T Cell LymphomaDiffuse Large B-cell LymphomaClassical Hodgkin Lymphoma+3 more
Pfizer 6
Early research (Phase 1)UnknownNCT05716919
What this trial is testing

Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule

Who this might be right for
Hematologic MalignancySolid TumorFibrosis
Machaon Biotherapeutics, Inc. 32
Not applicableUnknownNCT04743388
What this trial is testing

Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System

Who this might be right for
COVID-19Healthy VolunteersChronic Disease+2 more
National and Kapodistrian University of Athens 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439266
What this trial is testing

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03678883
What this trial is testing

9-ING-41 in Patients With Advanced Cancers

Who this might be right for
CancerPancreatic CancerSarcoma+22 more
Actuate Therapeutics Inc. 350
Early research (Phase 1)Study completedNCT04944888
What this trial is testing

GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor

Who this might be right for
Solid TumorHematologic Malignancy
Chinese PLA General Hospital 31
Testing effectiveness (Phase 2)Study completedNCT03365791
What this trial is testing

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Who this might be right for
Small Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more
Novartis Pharmaceuticals 76
Testing effectiveness (Phase 2)Study completedNCT02419417
What this trial is testing

Study of BMS-986158 in Subjects With Select Advanced Cancers

Who this might be right for
Advanced Tumors
Bristol-Myers Squibb 83
Not applicableStudy completedNCT06881108
What this trial is testing

Addressing Financial Hardship in Adolescent and Young Adult Cancer Survivors

Who this might be right for
Hematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm
Wake Forest University Health Sciences 16
Not applicableActive Not RecruitingNCT05102656
What this trial is testing

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 107
Testing effectiveness (Phase 2)Looking for participantsNCT06395103
What this trial is testing

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt Lymphoma+2 more
Merck Sharp & Dohme LLC 90
Testing effectiveness (Phase 2)Study completedNCT01902173
What this trial is testing

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmLocally Advanced Malignant Solid NeoplasmLocally Advanced Melanoma+6 more
National Cancer Institute (NCI) 27
Early research (Phase 1)Study completedNCT01912222
What this trial is testing

Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction

Who this might be right for
Advanced Solid TumorsHematologic Malignancies
Millennium Pharmaceuticals, Inc. 48
Testing effectiveness (Phase 2)WithdrawnNCT04439305
What this trial is testing

Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes (MATCH-Subprotocol X)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Active Not RecruitingNCT04939090
What this trial is testing

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

Who this might be right for
Advanced Malignant Solid NeoplasmAnorexiaHematopoietic and Lymphoid Cell Neoplasm
Alliance for Clinical Trials in Oncology 227
Not applicableActive Not RecruitingNCT04592250
What this trial is testing

Financial Toxicity in Cancer Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 625
Testing effectiveness (Phase 2)Study completedNCT01831726
What this trial is testing

Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib

Who this might be right for
Tumor Pathway Activations Inhibited by Dovitinib
Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439149
What this trial is testing

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 24
Not applicableLooking for participantsNCT06989489
What this trial is testing

Implementation of an Oral Chemotherapy Adherence Intervention

Who this might be right for
Solid TumorHematologic Malignancy
UNC Lineberger Comprehensive Cancer Center 160
Next Page